Healthwise: Exploring immunotherapy for carcinoid and pancreatic neuroendocrine tumors – MyCentralJersey.com
MyCentralJersey.com |
Healthwise: Exploring immunotherapy for carcinoid and pancreatic neuroendocrine tumors
MyCentralJersey.com A clinical trial testing the immunotherapy drug pembrolizumab shows the drug to be well tolerated among patients who have carcinoid or pancreatic neuroendocrine tumors. Dr. Janice M. Mehnert, MD, director of the Phase 1 and Developmental Therapeutics … |
